Search & Analyze
Popular Searches
Alembic Pharmaceuticals Ltd.
Healthcare₹795.950.37%
24 Jul, 4:01 PM
CMP₹795.95
Mkt Cap₹15.61K Cr
P/E23.13
P/B2.75
ROE12.35%
52W High₹1,029.50
52W Low₹635.30
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
23.13
P/B Ratio
2.75
EV/EBITDA
14.29
Price/Sales
2.13
Dividend Yield (%)
1.51
EPS (TTM ₹)
34.33
Book Value (₹)
288.70
ROE (%)
12.35
ROCE (%)
11.74
ROA (%)
8.23
EBITDA Margin (%)
7.84
Net Profit Margin (%)
4.71
Debt/Equity
0.24
Current Ratio
1.73
Interest Coverage
8.41
Asset Turnover
1.75
Working Capital/Sales
7.31
Core EBITDA Growth (%)
11.62
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 5305.78 | 5652.62 | 6228.63 | 6672.08 | 7344.9 |
| Net Sales | 5305.78 | 5652.62 | 6228.63 | 6672.08 | 7344.9 |
| Total Income | 5356.27 | 5655.66 | 6257.67 | 6719.94 | 7399.78 |
| Total Expenditure | 4431.64 | 4944.56 | 5296 | 5669.16 | 6226.9 |
| Operating Profit | 924.63 | 711.1 | 961.67 | 1050.78 | 1172.88 |
| Depreciation | 286.78 | 275.43 | 272.67 | 278.57 | 318.55 |
| Exceptional Items | — | — | — | 12.87 | -66.99 |
| Profit Before Tax | 625.4 | 354.59 | 631.83 | 707.18 | 693.95 |
| Tax | 104.46 | 12.6 | 16.01 | 125.17 | 23.12 |
| Profit After Tax (PAT) | 520.94 | 341.99 | 615.82 | 582.01 | 670.83 |
| EPS (₹) | 26.5 | 17.4 | 31.33 | 29.68 | 34.33 |
| Dividend Payout % | 500 | 400 | 550 | 550 | 600 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 39.31 | 39.31 | 39.31 | 39.31 | 39.31 |
| Reserves | 5198.23 | 4331.16 | 4778.89 | 5151.63 | 5635.5 |
| Shareholders Funds | 5237.54 | 4370.47 | 4818.2 | 5190.94 | 5674.81 |
| Total Debt | 629.99 | 635.87 | 430.45 | 1195.57 | 1360.85 |
| Total Liabilities | 7230.2 | 6063.69 | 6341.23 | 7708.84 | 8586.01 |
| Total Assets | 7230.2 | 6063.69 | 6341.23 | 7708.84 | 8586.01 |
| Book Value / Share | 266.4737 | 222.3592 | 245.1386 | 264.1028 | 288.7209 |
| Assets | 7230.2 | 6063.69 | 6341.23 | 7708.84 | 8586.01 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 552.35 | 723.94 | 803.2 | 87.96 | 782.73 |
| Investing Activities | -371.97 | -447.59 | -320.61 | -568.41 | -506.06 |
| Financing Activities | -217.35 | -261.96 | -437.86 | 443.72 | -163.78 |
| Net Cash Flow | -36.97 | 14.39 | 44.73 | -36.73 | 112.89 |
APLLTD
₹795.95
-0.37%